CUI · 40510432 · J29512/2019 · PRAHOVA
AYUVERDA MEDICAL S.R.L.
Str. POȘTEI, Nr. 35
Ploiești, PRAHOVA, 100162
ANAF Live Status
Synced 9d agoSource: ANAF PlatitorTvaRest v9 (public API · no auth · daily sync). Covers VAT registration, cash-basis VAT, split-payment VAT, e-Factura enrollment, and fiscal inactivity.
People
1 representative- R🇷🇴Administrator
R*** C****
Revenue · 2024
168.9K RON
Net Profit · 2024
22.9K RON
Employees · 2024
3
Equity · 2024
-100.1K RON
Registration
Tax Status
Address
Ploiești
PRAHOVA
100162
Financial Health Score
Altman Z″ inputs · 2024
- WC / TA
- -0.45
- RE / TA
- -1.11
- EBIT / TA
- 0.29
- Eq / Liab
- -0.80
How is this calculated?
We apply the Altman Z″, a bankruptcy-prediction score published by Edward Altman for private, non-manufacturing companies. It combines four ratios — each captures a different aspect of financial health — and weights them:
Z″ = 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4
- X1 — Working Capital / Total Assets · short-term liquidity.
- X2 — Retained Earnings / Total Assets · cumulative profitability.
- X3 — EBIT / Total Assets · operating efficiency.
- X4 — Equity / Total Liabilities · solvency buffer.
Thresholds (Altman, 2000): Distress < 1.1, Grey 1.1–2.6, Safe > 2.6.
The 0–100 score is a linear mapping of clamped Z″ in the [0, 5] range — a visual shorthand, not an additional metric. Hover any year on the chart to see the per-year breakdown.
Caveats: Romanian bilanț doesn't split liabilities into short/long-term, so we approximate current liabilities as 0.7·I7 (SME heuristic). EBIT is approximated with I16 (gross profit), since interest is bundled into I15.
Z″ over time
Distress < 1.1 · Caution 1.1–2.6 · Safe > 2.6
Financial Performance
14 years of reporting
All figures sourced from ANAF and Ministerul Finanțelor filings. Click any data point to explore.
2011 — 2024
Net turnover (revenue) & Net Profit
Assets × Liabilities
Balance Sheet Overview
Revenues vs expenses
Total revenues vs Total expenses
Since 2016
Avg. number of employees
Year 2024
Asset Breakdown
Raw Data
Raw Financial Data
| Year | Net turnover (revenue) | Net profit | Total liabilities | Fixed assets | Current assets | Shareholders' equity | Avg. number of employees | Inventories | Receivables | Cash & bank accounts | Prepaid expenses | Deferred revenue | Provisions | Paid-in share capital | State patrimony | Total revenues | Total expenses | Gross profit | Gross loss | Net loss |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 168.921 -50.4% | 22.926 -46.2% | 125.332 -18.7% | 42.536 -46.9% | 47.614 +2.1% | -100.069 +13.1% | 3 -40.0% | — | 31.878 +9.1% | 15.736 -9.6% | — | 64.887 -26.0% | — | 200 +0.0% | — | 191.693 -47.3% | 165.189 -48.0% | 26.504 -41.9% | 0 | 0 |
| 2023 | 340.667 +0.9% | 42.582 -34.8% | 154.228 -30.0% | 80.139 -46.3% | 46.625 -51.1% | -115.122 -33.6% | 5 +25.0% | — | 29.210 -68.1% | 17.415 +356.6% | — | 87.658 -20.6% | — | 200 +0.0% | — | 363.441 +0.9% | 317.839 +8.9% | 45.602 -33.3% | 0 | 0 |
| 2022 | 337.534 +73.3% | 65.329 +521.7% | 220.352 -51.2% | 149.191 -56.6% | 95.398 -12.8% | -86.192 -5368.5% | 4 +33.3% | — | 91.584 +77.9% | 3.814 -93.4% | — | 110.429 | — | 200 +0.0% | — | 360.307 +55.2% | 291.910 +32.9% | 68.397 +450.3% | 0 | 0 |
| 2020 | 194.734 +175.5% | 10.508 | 451.161 +51.2% | 343.391 +91.7% | 109.406 -0.9% | 1.636 +118.4% | 3 +50.0% | — | 51.485 +885.4% | 57.921 +13.6% | — | — | — | 200 +0.0% | — | 232.150 +228.4% | 219.720 +177.8% | 12.430 | 0 -100.0% | 0 -100.0% |
| 2019 | 70.672 | 0 | 298.454 | 179.143 | 110.439 | -8.872 | 2 | 54.248 | 5.225 | 50.966 | — | — | — | 200 | — | 70.701 | 79.080 | 0 | 8.379 | 9.072 |